MM-1053: Cardiovascular Risk of CAR T-Cell and Bispecific Immunotherapies in Relapsed or Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
Clinical Lymphoma Myeloma and Leukemia
Conference Name
Society of Hematologic Oncology (SOHO) Annual Meeting
Conference Date
2025-09-03 - 2025-09-06
First Page
S961
DOI
10.1016/S2152-2650(25)02678-3
Volume
25
Issue
Supplement 1
Publication Date
9-1-2025
Recommended Citation
Kodali, L. S., Mylavarapu, M., Pasnoor, D. S., Ganatra, N., Jain, P., & Sanjeevi, A. (2025). MM-1053: Cardiovascular Risk of CAR T-Cell and Bispecific Immunotherapies in Relapsed or Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia, 25 (Supplement 1), S961. https://doi.org/10.1016/S2152-2650(25)02678-3
COinS